{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:44:13Z","timestamp":1778078653348,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007812","name":"Washington University","doi-asserted-by":"crossref","award":["UR1TR002345"],"award-info":[{"award-number":["UR1TR002345"]}],"id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007812","name":"Washington University","doi-asserted-by":"crossref","award":["KL2TR000450"],"award-info":[{"award-number":["KL2TR000450"]}],"id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences (NCATS)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007812","name":"Washington University","doi-asserted-by":"crossref","award":["UL1TR002345"],"award-info":[{"award-number":["UL1TR002345"]}],"id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.urology.2018.08.039","type":"journal-article","created":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T12:00:31Z","timestamp":1536408031000},"page":"76-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Antimuscarinic Use in Men Treated With Bladder Outlet Obstruction Medication Therapy"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0411-2160","authenticated-orcid":false,"given":"Scott Martin","family":"Vouri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth A.","family":"Strope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Xian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Schootman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2018.08.039_bib0001","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.2004.05039.x","article-title":"Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder","volume":"94","author":"Lee","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2018.08.039_bib0002","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society","volume":"61","author":"Abrams","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2018.08.039_bib0003","series-title":"Management of Benign Prostatic Hyperplasia (BPH)","author":"McVary","year":"2014"},{"key":"10.1016\/j.urology.2018.08.039_bib0004","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/01.ju.0000067541.73285.eb","article-title":"Combination treatment with an \u03b1-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study","volume":"169","author":"Athanasopoulos","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.08.039_bib0005","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","article-title":"Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial","volume":"296","author":"Kaplan","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2018.08.039_bib0006","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.eururo.2012.07.003","article-title":"Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial","volume":"63","author":"Kaplan","year":"2013","journal-title":"Euro Urol"},{"key":"10.1016\/j.urology.2018.08.039_bib0007","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.juro.2009.08.023","article-title":"Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency","volume":"182","author":"Kaplan","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2018.08.039_bib0008","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.urology.2011.02.055","article-title":"Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms\u2014ASSIST, randomized controlled study","volume":"78","author":"Yamaguchi","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urology.2018.08.039_bib0009","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4065\/83.9.1002","article-title":"Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study","volume":"83","author":"MacDiarmid","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.urology.2018.08.039_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MOU.0b013e3283330862","article-title":"Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia","volume":"20","author":"Chapple","year":"2010","journal-title":"Cur Opin Urol"},{"key":"10.1016\/j.urology.2018.08.039_bib0011","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.urology.2013.07.062","article-title":"Trends in medical management of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia","volume":"82","author":"Filson","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.urology.2018.08.039_bib0012","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.annemergmed.2012.07.010","article-title":"Understanding and interpreting the National Hospital Ambulatory Medical Care Survey: key questions and answers","volume":"60","author":"McCaig","year":"2012","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.urology.2018.08.039_bib0013","unstructured":"Scope and Sample Design. Ambulatory Health Care Data 2015; https:\/\/www.cdc.gov\/nchs\/ahcd\/ahcd_scope.htm#namcs_scope. Accessed August 27, 2018."},{"key":"10.1016\/j.urology.2018.08.039_bib0014","article-title":"Overactive bladder","author":"Wallace","year":"2015","journal-title":"F1000Res. 2015;4:1406"},{"key":"10.1016\/j.urology.2018.08.039_bib0015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1310\/hpj4803-196","article-title":"Prazosin: benign prostatic hyperplasia","volume":"48","author":"Generali","year":"2013","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.urology.2018.08.039_bib0016","unstructured":"Trend Analysis Using NAMCS and NHAMCS Drug Data. Ambulatory Health Care Data 2015; https:\/\/www.cdc.gov\/nchs\/ahcd\/trend_analysis.htm. Accessed August 27, 2018."},{"key":"10.1016\/j.urology.2018.08.039_bib0017","series-title":"Considerations and Techniques for Analyzing Domains of Complex Survey Data","author":"Lewis","year":"2013"},{"key":"10.1016\/j.urology.2018.08.039_bib0018","series-title":"Try, Try Again: Replication-Based Variance Estimation Methods for Survey Data Analysis in SAS 9.2","author":"Mukhopadhyay","year":"2008"},{"key":"10.1016\/j.urology.2018.08.039_bib0019","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/pcan.2011.22","article-title":"Initial combined treatment with anticholinergics and alpha-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study","volume":"14","author":"Lee","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urology.2018.08.039_bib0020","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/ijcp.12483","article-title":"Persistence with solifenacin add-on therapy in men with benign prostate obstruction and residual symptoms of overactive bladder after tamsulosin monotherapy","volume":"68","author":"Lee","year":"2014","journal-title":"Int J Clin Pract"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518309464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518309464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T17:20:33Z","timestamp":1544548833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429518309464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":20,"alternative-id":["S0090429518309464"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2018.08.039","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimuscarinic Use in Men Treated With Bladder Outlet Obstruction Medication Therapy","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2018.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}